Biogen Inc. (BIIB) News Headlines

▮ More

Date

Headline

5/3/2022 7:44:20 AM Biogen Reaffirms FY22 Outlook; Q1 Adj. EPS Misses Estimates

5/3/2022 7:16:47 AM Biogen Q1 GAAP EPS $2.06; Non-GAAP EPS $3.62

5/3/2022 6:00:23 AM Biogen Q1 22 Earnings Conference Call At 8:00 AM ET

5/2/2022 6:36:06 AM Sage Therapeutics, Biogen Begin Rolling Submission Of NDA To US FDA For Zuranolone For Potential Treatment Of MDD

3/30/2022 8:31:30 AM Biogen Submits Final Protocol For Envision Trial Of Aduhelm On Alzheimer's Disease

3/30/2022 7:46:04 AM Biogen Submits Final Protocol For ADUHELM Phase 4 ENVISION Trial To FDA

3/28/2022 8:17:06 AM Biogen : Phase 1 Study Of BIIB078 On Amyotrophic Lateral Sclerosis Fails To Meet Secondary Endpoints

3/28/2022 7:34:53 AM Biogen : Phase 1 Study Of BIIB078 On Amyotrophic Lateral Sclerosis Did Not Meet Any Secondary Efficacy Endpoints

3/17/2022 10:00:20 PM Viatris Says Defeats Biogen's Attempt To Revive Tecfidera Patent

3/16/2022 9:07:20 AM Biogen: ADUHELM Continues To Reduce Underlying Pathologies Of Alzheimer's Beyond Two Years

3/16/2022 7:40:48 AM Biogen Inc. Announces Data From Long-term Extension Study Of ADUHELM

3/15/2022 12:01:09 AM Biogen, Eisai Amend Collaboration Agreement On Alzheimer's Disease Treatments

3/4/2022 9:14:07 PM Charles Schwab To Replace Biogen In S&P 100

2/16/2022 8:11:27 AM Sage : Phase 3 Study Of Zuranolone On Major Depressive Disorder Meets Primary & Secondary Endpoints

2/7/2022 9:11:50 PM Biogen Reaches Deal With Xbrane For Proposed Biosimilar To Cimzia

2/3/2022 7:35:30 AM Biogen Posts Adj. Profit In Q4; Sees FY22 Results Below Market

2/3/2022 7:05:25 AM Biogen Q4 EPS $2.50; Non-GAAP EPS $3.39

2/3/2022 6:00:30 AM Biogen Q4 21 Earnings Conference Call At 8:00 AM ET

1/31/2022 7:34:14 AM Biogen Announces Nancy Leaming And Brian Posner To Retire From Board

1/27/2022 9:43:51 PM Samsung Biologics To Buy Biogen's Stake In Samsung Bioepis JV For Up To $2.3 Bln